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Abstract A recent genome-wide association study elu-
cidated that 4q25 was implicated in ischemic stroke, but
subsequent studies showed inconsistent results. In order to
get coincident conclusion, we investigated two SNPs
(rs2200733, rs10033464) on chromosome 4q25 in 1,388
stroke patients and 1,629 controls from Chinese Han pop-
ulation and then performed a meta-analysis. Although we
failed to detect any association between 4q25 and stroke in
our case–control study, meta-analysis revealed that
rs2200733 showed association with overall stroke (OR
1.18, 95 % CI 1.08–1.27), but not for rs10033464. Subse-
quently subgroup analysis indicated that both rs2200733
and rs10033464 conferred increased risk for cardioembolic
stroke (CE stroke) (for rs2200733, OR 1.38, 95 % CI
1.26–1.51; for rs10033464, OR 1.14, 95 % CI 1.02–1.26),
while rs2200733 was marginal associated with non-CE
stroke (OR 1.09, 95 % CI 1.02–1.16). our results demon-
strated that two SNPs (rs2200733 and rs1003346) on
chromosome 4q25 were limited to the stroke of cardio-
embolic etiology. To confirm this conclusion, well-
designed studies with larger sample size involving case–
control populations with homogeneous ancestry warrant to
be conducted in the future.
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Introduction
Stroke is a multifactorial complex disorder causing long-
term disability and increasing family responsibilities [1].
With high morbidity and mortality, stroke has become the
first cause of death in China [2]. It was no doubt that
environmental and clinical risk factors (such as hyperten-
sion, diabetes, hyperlipidemia, high body mass index
(BMI) and smoking state etc.) contributed to the progress
of stroke [3, 4], however twin and family history studies
suggested that a genetic component also played an
important role [5, 6]. Recently, a GWAS from Iceland
found that rs2200733 and rs10033464 on chromosome
4q25 both were strongly associated with stroke [7]. How-
ever, a series of later studies failed to replicate this result
and obtained inconsistent results [8–15]. Aiming to get
reliable and stable conclusion about the relationship
between 4q25 and stroke, we analyzed two SNPs
(rs2200733 and rs10033464) on chromosome 4q25 in
Chinese Han population, including 1,388 stroke patients
and 1,629 controls. Then, we combined our study with
previously published articles to conduct a meta-analysis to
asses the relationship between these two SNPs and the risk
of overall stroke and subtypes.
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This is a multicenter study sponsored by the Ministry of
Science and Technology of China. Briefly, a total of 1,388
stroke patients were recruited in our study between
November 2004 and January 2009 from five hospitals in
Wuhan, China: atherothrombotic stroke (thrombosis,
n = 716), lacunar infarction (lacuna, n = 407), and en-
tracerebral hemorrhage (hemorrhage, n = 265). The
inclusion criteria and description about stroke subjects
have been previously reported [16]. Ethnically and geo-
graphically matched controls (n = 1,629) were randomly
selected from the healthy, community-based residents by
house-to-house recruitment. All the study protocols were
approved by the review board of the Ministry of Public
Health, Ministry of Science and Technology of China and
the ethics committees at all participating hospitals (Tongji
Hospital, Union Hospital, Xinhua Hospital, First Wuhan
Hospital and Wugang Hospital), and informed written
consent was obtained from all participants. Experiments
were conducted according to the principles expressed in the
Declaration of Helsinki.
DNA isolation and genotyping
Genomic DNA was extracted using the QG-Mini80
workflow with a DB-S kit (FUJIFILM Corporation, Tokyo,
Japan) as instructed. The SNPs were genotyped using the
TaqMan SNP allelic discrimination on the TaqManTM
7900HT Sequence Detection System under standard con-
ditions as previously described [17]. Probe and primer
sequences for these assays were custom designed by ABI
Primer Expression 3.0 software and synthesized by Gene-
Core BioTechnologies Company, Limited, Shanghai,
China (supplementary Table 1). Allelic discrimination was
measured automatically using the Sequence Detection
Systems 2.1 software (autocaller confidence level 95 %). A
total of 10 % of all genotypes were repeated in independent
PCRs to check for consistency and to ensure intraplate and
interplate genotype quality control. No genotyping dis-
crepancies were detected between the repeated samples. In
addition, all the DNA samples for cases and controls were
run in the same batch. In order to verify the accuracy of
Taqman probe method for genotyping, we randomly
selected 151 (about 5 % of sample size) samples from
cases and controls to conduct direct DNA sequence ana-
lysis using the BigDye Terminator v3.1 Cycle Sequenc-
ing Kits on an ABI PRISM 3130xl Genetic Analyzer
(Applied Biosystems, Foster City, CA, USA). At last, we
found these two different genotyping methods were highly
consistent.
Statistical analysis
All quantitative variables were generally described as means
with standard deviation (SD). one-way ANOVA test was
performed to compare the baseline characteristics of differ-
ent groups, such as age, BMI etc.; v2 test was used for
qualitative variables. Multiple unconditional logistic
regression was used to estimate odds ratio (OR) and 95 %
confidence interval (CI) under different genetic models after
adjusting for gender, age, BMI, hypertension, diabetes,
hyperlipidemia and smoking status. Haplotype frequencies
for these two SNPs combinations were first estimated by
haplo.stats (version 12.1) for the R statistical package and
then verified using Haploview 4.0. Both of the software
above uses the expectation–maximization (EM) algorithm
when constructing the haplotypes. Global score tests were
applied to evaluate overall haplotype frequency differences
between cases and controls, whereas the haplotype-specific
score tests were performed to test individual haplotype dif-
ference between cases and controls. To minimize the false-
positive results generated from multiple statistical testing in
our aforementioned analyses, we adopted the Bonferroni
correction method for multiple testing.
Literature search
We systematically searched in Pubmed, Embase and CNKI up
until December, 2012 using the key words ‘‘stroke’’, ‘‘ische-
mic stroke’’, ‘‘cerebral infarction’’, ‘‘cerebrovascular disease’’
paired with ‘‘4q25’’, ‘‘SNP’’, ‘‘PITX2’’, ‘‘rs2200733’’ and
‘‘rs10033464’’, respectively. Reference lists of relevant arti-
cles were also screened. The study inclusion criteria were as
follows: (1) articles published in English or Chinese, (2) case–
control or population-based studies, (3) studies with complete
data on allele frequency and relevant clinical base character-
istics, (4) studies about the association between rs2200733 or
rs10033464 and stroke. Exclusion criteria were: (1) overlap-
ping data, (2) case-only study, (3) small number cases, (4)
review, (5) uncompleted article.
Data extraction
Two investigators independently extracted useful data from
the articles meeting the inclusion criteria, including first
author name, publication year, number of stroke patients
and controls, ORs (HRs) and 95 % CI. Disagreements were
resolved by discussion.
Statistical meta-analysis
All meta-analyses were performed by STATA software
(version10.0). Pooled OR and 95 % CI were used to assess the
association between rs2200733 or 10033464 and stroke.
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Heterogeneity was calculated by Cochran’s Q statistic and
inconsistency index (I2). If probability values \0.10 or
I2 [ 0.50, heterogeneity was considered [18]; the random
effects model was selected to estimate the pooled OR.
Otherwise fixed effects model was applied. In order to reduce
the heterogeneity of the meta-analysis, then, we performed
subgroup analysis. Sensitivity analyses were used by omitting
one cohort or one study at one time and calculating the pooled
ORs of remaining cohorts or studies to assess the stability of
our results. To test the publication bias, Begg’ funnel plot and
Egger’ test were operated, All P values were two-tailed and
P \ 0.05 was considered statistically significant.
Results
Allelic association of SNPs in 4q25 and stroke
The characteristics of our study cohorts were shown in
Table 1. Rs2200733 and rs10033464 genotypes were found
to be in Hardy–Weinberg equilibrium in controls (both
P [ 0.05). Multivariate unconditional logistic regression
analyses revealed that rs10033464 conferred risk for
intracerebral hemorrhage in additive model (OR 1.29,
95 % CI 1.02–1.24, P = 0.038) and dominant model (OR
1.47, 95 % CI 1.08–1.97, P = 0.015); rs2200733 was not
associated with overall stoke and subtypes (Table 2).
However, none of associations remained significant with
adjustment of Bonferroni correction.
Haplotype analysis for these two SNPs
The correlation of two SNPs (rs2200733 and rs10033464)
within the region of 4q25 is weak in our control data set
(D0 = 0.91, r2 = 0.24). We used the haplo.stats program to
determine whether the combined effects of two SNPs
(rs2200733 and rs10033464) were associated with overall
stroke and subtypes. As shown in Table 3, we failed to
detect a significant difference for these two SNPs for all the
Table 1 Baseline characteristics of stroke samples
Characteristics Controls Cases Thrombosis Lacunar Hemorrage
n = 1,629 n = 1,388 n = 716 n = 407 n = 265
Age (years) 59.29 ± 10.1 61.2 ± 10.4a 60.9 ± 10.4a 64.4 ± 9.0a 57.14 ± 11.0a
Male (%) 43.2 66.1a 66.9a 64.6a 66.6a
BMI (kg/m2) 24.2 ± 3.4 24.2 ± 3.3 24.3 ± 3.2 24.3 ± 3.5 23.8 ± 3.5
SBP (mmHg) 130.0 ± 20.7 148.3 ± 23.0a 147.6 ± 24.1a 145.4 ± 21.9a 154.5 ± 25.5a
DBP (mmHg) 80.3 ± 22.3 87.1 ± 13.8a 86.4 ± 14.6a 84.4 ± 12.6a 93.2 ± 16.7a
Hypertension (%) 28.1 68.7a 69.4a 68.8a 66.6a
Diabetes (%) 6.4 15.6a 18.9a 16.5a 5.3
Hyperlipidemia (%) 23.6 25.2 29.3 27.5 10.6a
Smokers (%) 27.1 51.1a 53.8a 50.6a 44.5a
Values are expressed as mean ± SD unless otherwise noted
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure
a Test for differences between cases and controls, P \ 0.01
Table 2 Associations of SNPs with overall stroke and subtypes in different genetic models
SNPs Subtypes Minor allele frequency ORs (95 % CI) P ORs (95 % CI) P ORs (95 % CI) P
Control/case Additive model Dominant model Recessive model
rs2200733 Thrombosis 0.473/0.467 1.03 (0.89–1.18) 0.705 1.00 (0.80–1.25) 0.998 1.08 (0.85–1.38) 0.518
Lacuna 0.473/0.456 0.96 (0.81–1.14) 0.618 1.10 (0.84–1.44) 0.485 0.78 (0.57–1.05) 0.100
Hemorrhage 0.473/0.458 0.98 (0.80–1.20) 0.817 1.08 (0.78–1.49) 0.636 0.85 (0.59–1.21) 0.358
All 0.473/0.462 1.00 (0.89–1.13) 0.982 1.05 (0.87–1.26) 0.613 0.95 (0.78–1.13) 0.606
rs10033464 Thrombosis 0.209/0.207 1.05 (0.88–1.25) 0.612 1.09 (0.88–1.35) 0.412 0.89 (0.55–1.45) 0.636
Lacuna 0.209/0.204 1.01 (0.82–1.25) 0.893 1.07 (0.83–1.38) 0.599 0.76 (0.40–1.43) 0.380
Hemorrhage 0.209/0.236 1.29 (1.02–1.64) 0.038 1.47 (1.08–1.97) 0.015 1.11 (0.59–2.07) 0.748
All 0.209/0.212 1.06 (0.92–1.22) 0.445 1.11 (0.93–1.32) 0.237 0.89 (0.60–1.32) 0.556
ORs and P value were estimated by multiple unconditional logistic regression after adjusting for gender, age, body mass index, hypertension,
diabetes, hyperlipidemia and smoking status
Mol Biol Rep (2013) 40:5977–5985 5979
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We initially obtained 345 potential articles, among which
most were excluded for no relevance to our analysis after
screening abstract. Nine articles remained to assess the full-
text. Three articles then were removed because overlapping
data [10, 13] and small number cases [14]. Finally, seven
articles (combining our study) including 11 data sets for
rs2200733 and 12 data sets for 10033464 met the inclusion
criteria (Fig. 1).
Association of rs2200733 polymorphism with the risk
of stroke
A total of 11 data sets from six studies (including our
study) for rs2200733 polymorphism were involved in our
meta-analysis containing 13,764 cases and 73,527 controls.
The characteristics of these studies were shown in Table 4.
In detail, seven data sets containing 3,825 cases and 40,980
controls described the association for CE stroke, as well as
eight data sets (9,939 cases and 60,486 controls) for non-
CE stroke. As shown in Fig. 2a, a random-effects model
was performed for meta-analysis and generated a combined
allelic OR of 1.18 for risk allele (95 % CI, 1.08–1.27) with
heterogeneity (Q = 29.67, I2 = 66.3 %). When restricted
to CE stroke subgroup studies, there was significant asso-
ciation between rs2200733 and the risk of CE stroke (OR
Table 3 Association of haplotypes with overall stroke and subtypes
Haplotypea Control All stroke Pb Thrombosis Pb Lacunar Pb Hemorrhage Pb
TGc 0.517 0.525 0.478 0.519 0.834 0.539 0.297 0.517 0.753
CG 0.275 0.265 0.36 0.275 0.927 0.275 0.388 0.248 0.175
CT 0.199 0.197 0.938 0.191 0.653 0.197 0.876 0.212 0.424
Global P = 0.680 Global P = 0.680 Global P = 0.601 Global P = 0.345
a Haplotype frequencies were inferred using the EM algorithm within the haplo.stats R package; haplotypes are not listed if all the estimated
frequencies are \0.02 in controls, patients with stroke
b P value based on haplotype-specific score tests
c Constituted by SNPs rs2200733 and rs10033464
345 potential articles 
 from database
336 articles excluded by 
abstract screened 
2 articles excluded for 
 overlapped data 
1 article excluded for  
small number cases 
9 articles assessed for 
eligibility





12 data sets 
Our study 
Fig. 1 Flow chart of the
selection of articles included in
this meta-analysis
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Fig. 2 Meta-analysis of the
association between rs2200733
and overall stroke, CE stroke
and non-CE stroke. The squares
and horizontal lines refer to the
study-specific OR and 95 % CI.
a Meta-analysis plot of
association between rs2200733
and overall stroke. b Meta-
analysis plot of association
between rs2200733 and CE
stroke. c Meta-analysis plot of
association between rs2200733
and non-CE stroke
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Fig. 3 Meta-analysis of the
association between rs10033464
and overall stroke, CE stroke
and non-CE stroke. The squares
and horizontal lines refer to the
study-specific OR and 95 % CI.
a Meta-analysis plot of
association between rs10033464
and overall stroke. b Meta-
analysis plot of association
between rs10033464 and CE
stroke. c Meta-analysis plot of
association between rs10033464
and non-CE stroke
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1.38, 95 % CI 1.26–1.51) (Fig. 2b) and no obvious heter-
ogeneity was found (Q = 6.64, I2 = 9.7 %). Figure 2c
showed the association between rs2200733 and non-CE
stroke (OR 1.09, 95 % CI 1.02–1.16) was marginal and the
heterogeneity of this meta-analysis reduced (Q = 10.86,
I2 = 35.5 %).
Association of rs10033464 and the risk of stroke
For rs10033464, 12 data sets (including our study) were
available including 11,809 stroke patients and 34,853
control subjects: 11 of them had subgroups about stroke
(CE stroke and non-CE stroke) and one cohort just dis-
cussed the relation to non-CE stroke (supplementary
Table 2). Figure 3 respectively presented the association
among rs10033464 and overall stroke, CE stroke, non-CE
stroke. Obviously, Fig. 3a showed no association was
found between rs10033464 and overall stroke (OR 1.04,
95 % CI 0.97–1.10) without heterogeneity (Q = 7.13,
I2 = 0.0 %). However, subgroup analysis demonstrated
that rs10033464 was significantly associated with CE
stroke (OR 1.14, 95 % CI 1.02–1.26) without heterogeneity
(Q = 7.58, I2 = 0.0 %) (Fig. 3b). No association was
found for non-CE stroke (OR 0.97, 95 % CI 0.90–1.03)
(Fig. 3c).
Publication bias and sensitivity analysis
We further investigated the publication bias of every meta-
analysis about rs2200733 and rs10033464 using Begg test
and funnel plot (supplementary Fig. 1a–f). There was no
evidence of publication bias (all P [ 0.05). The sensitivity
analysis also illuminated that none of including studies or
cohorts influenced the stability of pooled ORs (supple-
mentary Fig. 2a–f).
Discussion
The two SNPs (rs2200733, rs10033464) on chromosome
4q25 were first found to be strongly associated with atrial
fibrillation (AF) in European descent by Gudbjartsson et al.
[19]. Another GWAS study verified these two variants also
contributed to ischemic stoke, especially cardioembolic
stroke [7]. However, the mechanism whereby the genetic
variants exert their same effects on these two related phe-
notypes remains to be elucidated. The most possible
explanation might be that the 4q25 locus associates with
AF and therefore indirectly also associates with CE stroke.
We carried out a case–control study and failed to rep-
licate the relevance of two SNPs and stroke in Chinese Han
population. This discrepancy may be explained by the
following reasons: (1) cardioembolic stroke as well as
stroke patients with AF were excluded from our study; (2)
these strongest signals may reflect genuine susceptibility
effects on cardioembolic stroke but not other subtypes; (3)
due to small sample size, we may lack enough power to
detect the associations between these two SNPs and stroke.
(4) genetic heterogeneity in different population. In China,
among all subtypes of stroke, intracerebral hemorrhage
accounts for 20–40 % of strokes in the Chinese population.
In contrast, the majority (80–90 %) of strokes in most
western populations are cerebral infarctions [20]. The
reasons for the high incidence of stroke, especially the
hemorrhagic subtype, among the Chinese population,
indicating different genetic background are more impli-
cated in the pathogenesis of disease development. Fur-
thermore, the distributions of these two SNPs were
different between various ethnic populations (for example,
the frequency of T allele for rs2200733 in Chinese popu-
lation is 0.537 compared to 0.104 in European cohorts
based on Hapmap database) and there was population-
specific genetic effect as a result of gene–gene and gene-
environment interactions.
Since the first description of the association between
4q25 and stroke, a number of replication studies with
conflicting results appeared. To date, there still was not
final and coherent conclusion. Hence, combining our own
cohort, we performed a meta-analysis for SNPs rs2200733
and rs10033464, respectively. Our meta-analysis harbored
impressively large sample size from different studies, so
the results seemed to be more reliable and stable than those
from single study. However, there are limitations in it: (1)
All included literatures were published in English or Chi-
nese, therefore, we might lose some articles meeting our
inclusion criteria but issued in other languages. (2) We
only recruited relevant papers which had been published,
so it was possible to miss some not published and inevi-
tably to cause publication bias. (3) The studies included
in our meta-analysis were all case–control studies or pop-
ulation-based studies, which precluded the further com-
ments on cause–effect relationship. (4) Although we
respectively carried out meta-analysis in CE stroke sub-
group and non-CE stroke subgroup, not all included asso-
ciated literatures had the data about subgroups. To some
extent, the meta-analysis results of non-CE stroke subgroup
were likely influenced by phenotypic misclassification. In
view of this, it seemed plausible that our result that
rs2200733 marginally associated with non-CE stroke sus-
ceptibility was not exactly true. The relevance between
rs2200733 and overall stroke was also affected by CE
stroke. So, we seem to conclude that rs2200733 only led to
CE stroke. (5) The population in our meta-analysis most
was from Europe and we failed to find any evidence to
report the association between these two SNPs and car-
dioembolic stroke in Chinese Han population after
5984 Mol Biol Rep (2013) 40:5977–5985
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extensively searching the literatures, thus studies under-
going in other countries or places (especially in China)
should be needed. (6) due to no association between these
two SNPs and AF were determinate in present study, we
did not know whether the association remained after
excluding the CE stroke patients with AF.
Conclusion
In conclusion, by combing all available data from genetic
studies on 4q25 and stroke, we confirmed rs2200733 and
rs10033464 both were associated with CE stroke. How-
ever, the molecular basis under it still needs to be eluci-
dated and well-designed studies with a large number of
subjects from different countries and regions should be
conducted in the future.
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